Authors:
WEIDMANN E
BRIEGER J
MIETHING CC
MAURER U
BERGMANN L
HOELZER D
MITROU PS
Citation: E. Weidmann et al., EXPRESSION OF THE WILMS-TUMOR GENE (WT-1) IN ACUTE MYELOCYTIC-LEUKEMIA (AML) - CLINICAL AND FUNCTIONAL FEATURES, Blood, 86(10), 1995, pp. 155-155
Authors:
BERGMANN L
WEIDMANN E
SCHUI D
HEIL G
LENGFELDER E
MITROU PS
HOELZER D
Citation: L. Bergmann et al., INTERLEUKIN-2 (IL2) IN THE MAINTENANCE THERAPY OF 2ND REMISSION OF AML - BASIS AND CLINICAL-RESULTS, Blood, 86(10), 1995, pp. 2987-2987
Authors:
BRIEGER J
WEIDMANN E
FENCHEL K
MITROU PS
HOELZER D
BERGMANN L
Citation: J. Brieger et al., THE EXPRESSION OF THE WILMS-TUMOR GENE IN ACUTE MYELOCYTIC LEUKEMIAS AS A POSSIBLE MARKER FOR LEUKEMIC BLAST CELLS, Leukemia, 8(12), 1994, pp. 2138-2143
Authors:
CONRAD B
WEIDMANN E
TRUCCO G
RUDERT WA
BEHBOO R
RICORDI C
RODRIQUEZRILO H
FINEGOLD D
TRUCCO M
Citation: B. Conrad et al., EVIDENCE FOR SUPERANTIGEN INVOLVEMENT IN INSULIN-DEPENDENT DIABETES-MELLITUS ETIOLOGY, Nature, 371(6495), 1994, pp. 351-355
Authors:
YASUMURA S
LIN WC
WEIDMANN E
HEBDA P
WHITESIDE TL
Citation: S. Yasumura et al., EXPRESSION OF INTERLEUKIN-2 RECEPTORS ON HUMAN CARCINOMA CELL-LINES AND TUMOR-GROWTH INHIBITION BY INTERLEUKIN-2, International journal of cancer, 59(2), 1994, pp. 225-234
Authors:
YASUMURA S
WEIDMANN E
HIRABAYASHI H
JOHNSON JT
HERBERMAN RB
WHITESIDE TL
Citation: S. Yasumura et al., HLA RESTRICTION AND T-CELL-RECEPTOR V-BETA GENE-EXPRESSION OF CYTOTOXIC T-LYMPHOCYTES REACTIVE WITH HUMAN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, International journal of cancer, 57(3), 1994, pp. 297-305
Authors:
BRIEGER J
JAHN B
FENCHEL K
WEIDMANN E
MITROU PS
BERGMANN L
Citation: J. Brieger et al., TRANSFORMING GROWTH-FACTOR TRANSCRIPTION AND RELEASE BY AML BLAST CELLS MAY INDICATE AN IMMUNOSUPPRESSIVE POTENTIAL, Experimental hematology, 21(8), 1993, pp. 1046-1046
Authors:
FENCHEL K
BRIEGER J
WEIDMANN E
MITROU PS
BERGMANN L
HOELZER D
Citation: K. Fenchel et al., HIGH EXPRESSION OF ICAM-1 ON LEUKEMIC-CELLS AND UP-REGULATION OF ITS LIGANDS ON LYMPHOCYTES BY IL-2 IN PATIENTS WITH AML, Experimental hematology, 21(8), 1993, pp. 1115-1115
Authors:
BERGMAN L
JAHN B
HEIL G
KOLBE K
LENGFELDER E
LOHMEYER J
FENCHEL K
WEIDMANN E
MITROU PS
HOELZER D
Citation: L. Bergman et al., INVERSION OF REMISSION DURATION IN 2ND REMISSION OF AML BY INTERLEUKIN-2 - THE ANTILEUCEMIC EFFECT MAY BE PREDOMINANTLY CAUSED BY AUTOLOGOUS CD4-CYTOTOXIC LYMPHOCYTES(), Experimental hematology, 21(8), 1993, pp. 1119-1119
Authors:
WEIDMANN E
ELDER EM
TRUCCO M
LOTZE MT
WHITESIDE TL
Citation: E. Weidmann et al., USAGE OF T-CELL RECEPTOR V-BETA CHAIN GENES IN FRESH AND CULTURED TUMOR-INFILTRATING LYMPHOCYTES FROM HUMAN-MELANOMA, International journal of cancer, 54(3), 1993, pp. 383-390
Authors:
WEIDMANN E
LOGAN TF
YASUMURA S
KIRKWOOD JM
TRUCCO M
WHITESIDE TL
Citation: E. Weidmann et al., EVIDENCE FOR OLIGOCLONAL T-CELL RESPONSE IN A METASTASIS OF RENAL-CELL CARCINOMA RESPONDING TO VACCINATION WITH AUTOLOGOUS TUMOR-CELLS AND TRANSFER OF IN-VITRO-SENSITIZED VACCINE-DRAINING LYMPH-NODE LYMPHOCYTES, Cancer research, 53(20), 1993, pp. 4745-4749
Authors:
BERGMANN L
FENCHEL K
WEIDMANN E
ENZINGER HM
JAHN B
JONAS D
MITROU PS
Citation: L. Bergmann et al., DAILY ALTERNATING ADMINISTRATION OF HIGH-DOSE INTERFERON-ALPHA-2B ANDINTERLEUKIN-2 BOLUS INFUSION IN METASTATIC RENAL-CELL CANCER - A PHASE-II STUDY, Cancer, 72(5), 1993, pp. 1733-1742
Authors:
KEILHOLZ U
SCHEIBENBOGEN C
TILGEN W
BERGMANN L
WEIDMANN E
SEITHER E
RICHTER M
BRADO B
MITROU PS
HUNSTEIN W
Citation: U. Keilholz et al., INTERFERON-ALPHA AND INTERLEUKIN-2 IN THE TREATMENT OF METASTATIC MELANOMA - COMPARISON OF 2 PHASE-II TRIALS, Cancer, 72(2), 1993, pp. 607-614
Authors:
FENCHEL K
BERGMANN L
CHRIST S
WEIDMANN E
BRIEGER J
MITROU PS
HOELZER D
Citation: K. Fenchel et al., PROGNOSTIC VALUE OF SIMULTANEOUS EXPRESSION OF CD7 AND CD33 ON LEUKEMIC BLASTS IN AML UNFAVORABLE OUTCOME OF PATIENTS WITH CD54+ BLASTS, Blood, 82(10), 1993, pp. 10000122-10000122